Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Improving consent processes for legal representatives in critical care clinical trials

Official title: Developing Strategies to Facilitate Consent of Legally Authorized Representatives to Clinical Trials - a Prospective, Single-arm, Open-label Exploratory Trial

Run by University Hospital Freiburg · NCT06471400 · Data updated 2026-11-12

This study is trying to understand how legal representatives feel about the process of getting consent for clinical trials involving critically ill patients, to make it easier for them to help with patient recruitment.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment50 (estimated)
SponsorUniversity Hospital Freiburg
Academic / other
Locations1 site (Freiburg im Breisgau)
StatusRecruiting
StartedJune 18, 2024
Main results expectedJune 17, 2026
Study endsDecember 31, 2026
Registry record updatedJune 24, 2024
Trial IDNCT06471400 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are legally authorized representatives of adult patients aged 18 years or older admitted to the Freiburg University Medical Center.

Probably not a fit

Patients who are not represented by a legally authorized representative or those who have expressed unwillingness to participate will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to understand the perceptions of legally authorized representatives (LARs) regarding the recruitment process for clinical trials involving critically ill patients who cannot provide consent themselves. By conducting interviews with LARs, the study seeks to identify their needs and concerns during the information and education process about clinical trials. The insights gained will help develop effective strategies to enhance LAR involvement and facilitate patient recruitment in these urgent medical situations. The study employs a single-arm design focusing on qualitative data without a comparator group.

Why it matters

Potential benefit: If successful, this study could lead to improved recruitment processes for clinical trials, ultimately benefiting critically ill patients through better access to potentially life-saving therapies.

How similar studies have gone: While the approach of enhancing consent processes for LARs is not widely tested, similar studies have shown that improving communication can positively impact recruitment in clinical trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The study will include LARs of adult patients aged 18 years or older who are admitted to the Freiburg University Medical Center in Germany.

Exclusion Criteria:

* LARs who have expressed their unwillingness to participate in the study or have objected to the measures implemented in the study will not be included.

Where it's running

  • Freiburg University Medical Center
    Freiburg im Breisgau, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.